Silver Book Fact

Use of tamoxifen, a drug used to treat breast cancer, has resulted in a direct cost savings of $41,372 per year of life gained in women 35- to 49-years-old, $68,349 in women 50- to 59-years-old, and $74,981 in women 60 to 69.

Joint Economic Committee. The Benefits of Medical Research and the Role of NIH. Apr-2000;

Reference

Title
The Benefits of Medical Research and the Role of NIH
Publisher
United States Senate: Office of the Chairman, Connie Mack
Publication Date
Apr-2000
Authors
Joint Economic Committee

Categories

  • Innovative Medical Research
  • Economic Value

Related Facts

  • Medicines Prevent Cancer Recurrence: New breast cancer drug greatly reduces recurrence and death (5 to 10 years after diagnosis in postmenopausal women)  
  • Medicines in Development for Cancer  
  • Chemotherapy drugs now target specific genomic abnormalities, about 150 effective drugs are available for cancer therapy, and new surgical techniques minimize negative consequences while producing better results.   
  • New Drug Increases Brain Cancer Survival Rate: Temozolomide is the first new drug in over 30 years to treat glioblastoma, a severe form of brain cancer  
  • A drug that can reduce the risk of breast cancer in high-risk women costs approximately $1,050 per year. The average cost per year for surgery or other invasive methods of…